You are now leaving our website and heading to a third-party website that we do not operate. We are not responsible for the content of the third-party website. You are advised to review its privacy policy as it may differ from ours.
Are you sure you want to leave?
Cancel
Complete the Medscape Education module, ‘Expert approaches: how to improve CKD–MBD management in daily practice’
The module is intended for an international audience of non-US physicians, specifically, nephrologists in Europe. You will not earn any continuing professional development (CPD) credits upon completing it, because it has expired. However, you should find great value in the wealth of practical advice provided by the experts who created it.
What will you learn?
Authored by Dr Smeeta Sinha,* Professor Kamyar Kalantar-Zadeh† and Professor Mario Cozzolino,‡ this CPD module is designed to:
- Improve your understanding of how chronic kidney disease–mineral and bone disorder (CKD–MBD) impacts patients when it is uncontrolled
- Enhance your competence in selecting the most appropriate regimens for treating hyperphosphataemia and secondary hyperparathyroidism (SHPT) in CKD patients
The module consists of an engaging and informative presentation, led by Dr Sinha. The presentation begins with a detailed patient case and is followed by practical clinical assessments by professors Kalantar-Zadeh and Cozzolino. All of the slides used in the presentation are available for download.
Released on 26 October 2020, the module is available until 26 October 2021.
Footnotes
*Consultant and Honorary Senior Lecturer, Nephrology; Salford Royal NHS Foundation Trust; Salford, United Kingdom.
†Professor of Medicine, Pediatrics and Nursing Sciences, and Epidemiology Chief; Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine; Irvine, California, United States.
‡Professor of Nephrology, University of Milan, and Director of the Renal Division, ASST Santi Paolo e Carlo; Milan, Italy.
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Ltd., a company of the Vifor Pharma Group, is the partner of choice for renal pharmaceutical and innovative, patient-focused solutions. The Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. The Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care. For more information about Vifor Pharma, please visit www.viforpharma.com
This site does not provide medical advice and may not be relied upon by any healthcare practitioner in exercising his or her professional judgement in the practice of medicine. The information provided herein is provided for general educational purposes only, and is not to be used or relied on for any diagnostic or treatment purposes. This material is not intended to represent the best or only methods or procedures appropriate for the medical situations discussed; rather the material is intended to present an approach, view, statement or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. VFMCRP makes no warranties or representations as to the site's accuracy, completeness or up-to-date information. All users agree that access to this site is at their own risk, and that neither VFMCRP any party involved in creating or delivering this site shall be liable for damages of any kind, including without limitation, any special, direct or indirect, incidental, or consequential or punitive damages (even if VFMCRP has been advised of the possibility of such damages) arising out of access to, or use of the information contained on this site, or any errors or omissions, misprints, out-of-date information, technical or pricing inaccuracies, typographical or other errors appearing on this site. This limitation includes damages to, or for any viruses that may infect your computer equipment.
© 2021 Vifor Fresenius Medical Care Renal Pharma
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Ltd., a company of the Vifor Pharma Group, is the partner of choice for renal pharmaceutical and innovative, patient-focused solutions. The Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology …
Read More
